Press Releases from DelveInsight Business Research LLP (4751 total)
CAR-T Cell Therapy Competitive Landscape 2024 (Updated) | CASI Pharmaceuticals, …
DelveInsight's, "CAR T Cell Therapy Competitive Landscape 2024" report provides comprehensive insights about 250+ CAR-T Cell Therapy companies and 500+ drugs in CAR T -…
Gene therapy Competitive Landscape Report 2024 (Updated) | Candel Therapeutics, …
DelveInsight's, "Gene Therapy Competitive Landscape 2024" report provides comprehensive insights about 250+ Gene Therapy companies and 300+ Gene Therapy drugs in the Gene therapy Competitive…
Bispecific Antibody Competitive Landscape Report 2024 (Updated) | Janssen, Amgen …
DelveInsight's, "Bispecific antibody Competitive landscape 2024" report provides comprehensive insights about 250+ Bispecific Antibody companies and 300+ Bispecific Antibody drugs in Bispecific antibody Competitive landscape.…
Antibody Drug Conjugate Competitie Landscape Report 2023 (Updated) | ImmunoGen, …
DelveInsight's, "Antibody Drug Conjugate Competitive Landscape 2023," report provides comprehensive insights about 180+ Antibody Drug Conjugate companies and 290+ Antibody Drug Conjugate drugs in Antibody…
Urothelial Carcinoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Urothelial Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 40+ Urothelial Carcinoma companies and 50+ pipeline drugs in the Urothelial Carcinoma pipeline landscape.…
EGFR Non-Small Cell Lung Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insights 2024" report provides comprehensive insights about 40+ EGFR Non-Small Cell Lung Cancer companies and…
Follicular Lymphoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Follicular Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 50+ Follicular Lymphoma companies and 50+ pipeline drugs in the Follicular Lymphoma pipeline landscape.…
Recurrent Glioblastoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Recurrent Glioblastoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Recurrent Glioblastoma pipeline landscape. It covers the…
Metastatic Renal Cell Carcinoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Metastatic Renal Cell Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Metastatic Renal Cell Carcinoma pipeline…
Mesothelioma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Mesothelioma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Mesothelioma pipeline landscape. It covers the pipeline drug…
Marginal Zone Lymphoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Marginal Zone Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Marginal Zone Lymphoma pipeline landscape. It…
Liver Cirrhosis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Liver Cirrhosis Pipeline Insight 2024" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Liver Cirrhosis pipeline landscape. It covers the…
Ischemic Stroke Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Ischemic Stroke Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Ischemic Stroke pipeline landscape. It covers the…
Huntington's Disease Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Huntington's Disease Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Huntington's Disease pipeline landscape. It covers the…
Human papillomavirus Associated Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Human papillomavirus (HPV) Associated Cancer Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Human papillomavirus (HPV) Associated…
HR Positive/ HER2 Negative Breast Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "HR Positive/ HER2 Negative Breast Cancer-Pipeline Insight, 2024," report provides comprehensive insights about 50+ companies and 53+ pipeline drugs in HR Positive/ HER2 Negative…
Dental Equipment Market to Witness a Robust Growth in the Upcoming Years | Major …
DelveInsight's "Dental Equipment Market Insight & Forecast" report will offer an in-depth understanding of the Dental Equipment market, further benefiting the competitors or stakeholders operating…
Mammography Devices Market Insight & Forecast Report | DelveInsight
The global market for mammography devices reached a value of USD 1.78 billion in 2020 and is projected to grow at a CAGR of 9.15%…
Hyperlipidemia Market to Show a Rise During the Forecast Period | Major players: …
DelveInsight's "Hyperlipidemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hyperlipidemia, historical and forecasted epidemiology as well as the Hyperlipidemia…
Typhoid Fever Market to Show a Rise During the Study Period | Teva Pharmaceutica …
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as…
Congenital Myasthenic Syndromes Market to Show a Rise During the Study Period | …
DelveInsight's "Congenital Myasthenic Syndromes Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Congenital Myasthenic Syndromes, historical and forecasted epidemiology as well…
Diabetic Kidney Disease Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMD …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Kidney Disease pipeline constitutes key companies continuously working towards developing Diabetic Kidney Disease…
Prostate Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Prostate Cancer Pipeline Insight 2024" report provides comprehensive insights about 140+ Prostate Cancer companies and 150+ Prostate Cancer pipeline drugs in Prostate Cancer pipeline…
Parkinson's Disease Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Parkinson's Disease Pipeline Insight 2024" report provides comprehensive insights about 140+ companies and 150+ pipeline drugs in Parkinson's Disease pipeline landscape. It covers the…
Non-Small Cell Lung Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Non-Small-Cell Lung cancer (NSCLC) Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Non-Small-Cell Lung cancer (NSCLC)…
Advanced Renal Cell Carcinoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Advanced Renal Cell Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in the Advanced Renal Cell Carcinoma…
Advanced Ovarian Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Advanced Ovarian Cancer Pipeline Insight 2024" report provides comprehensive insights about 50+ Advanced Ovarian Cancer companies and 50+ Advanced Ovarian Cancer pipeline drugs in…
Psoriatic Arthritis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Psoriatic Arthritis Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the Psoriatic Arthritis pipeline landscape. It covers…
Psoriasis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Psoriasis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Psoriasis pipeline landscape. It covers the pipeline…
Advanced Hepatocellular Carcinoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Advanced Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Advanced Hepatocellular Carcinoma pipeline landscape.…
Advanced Gastric Carcinoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Advanced Gastric Carcinoma Pipeline Insight, 2023," report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Advanced Gastric Carcinoma pipeline landscape.…
Advanced Cervical Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Advanced Cervical Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ Advanced Cervical Cancer companies and 75+ Advanced Cervical Cancer pipeline drugs in…
Encephalopathy Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Encephalopathy Pipeline Insight 2024" report provides comprehensive insights about 70+ Encephalopathy companies and 70+ pipeline drugs in the Encephalopathy pipeline landscape. It covers the…
Encephalopathy Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Endometrial Cancer Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Endometrial Cancer pipeline landscape. It covers the…
Functional Dyspepsia Market to Show a Rise During the Study Period | Takeda Phar …
DelveInsight's "Functional Dyspepsia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Functional Dyspepsia, historical and forecasted epidemiology as well as…
Ependymoma Market to Show a Rise During the Study Period | Fera Pharmaceuticals, …
DelveInsight's "Ependymoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Ependymoma, historical and forecasted epidemiology as well as the Ependymoma…
Chronic Spontaneous Urticaria Market to Show a Rise During the Study Period | Sa …
DelveInsight's "Chronic Spontaneous Urticaria Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Spontaneous Urticaria, historical and forecasted epidemiology as…
Gender Dysphoria Market to Show a Rise During the Study Period | Valera Pharmace …
DelveInsight's "Gender Dysphoria Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gender Dysphoria, historical and forecasted epidemiology as well as…
Germany Healthcare Outlook Report 2023 by DelveInsight | Fresenius AG, Bayer AG, …
DelveInsight's "Germany Healthcare Outlook Report, 2023," report provides comprehensive insights into the healthcare scenario, regulatory policies, and reimbursement landscape in Germany. The report also identifies…
Biopsy Devices Pipeline Insight and Competitive Landscape 2023 | Biopsy Devices …
DelveInsight's "Biopsy Devices - Pipeline Insight and Competitive Landscape 2023," report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the biopsy devices…
Bacterial Conjunctivitis Market to Show a Rise During the Study Period | Boehrin …
DelveInsight's "Bacterial Conjunctivitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Bacterial Conjunctivitis, historical and forecasted epidemiology as well as…
Infliximab Biosimilar Insights Report 2023 by DelveInsight | Celltrion, Pfizer, …
DelveInsight's "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the…
Eosinophilic Asthma Market to Show a Rise During the Study Period | Teva Pharmac …
DelveInsight's "Eosinophilic Asthma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Eosinophilic Asthma, historical and forecasted epidemiology as well as…
Cushing's Syndrome Market to Show a Rise During the Study Period | Corcept Thera …
DelveInsight's "Cushing's Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cushing's Syndrome, historical and forecasted epidemiology as well as…
Dry Eye Disease Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Dry Eye Disease Pipeline Insight 2024" report provides comprehensive insights about 45+ Dry Eye Disease companies and 50+ Dry Eye Disease pipeline drugs in…
Diabetic Retinopathy Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Diffuse Large B-Cell Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 80+ Diffuse Large B Cell Lymphoma companies and 80+ Diffuse Large B…
Diabetic Retinopathy Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Diabetic Retinopathy Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers…
Diabetic Macular Edema Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2024" report provides comprehensive insights about 60+ Diabetic Macular Edema companies and 65+ Diabetic Macular Edema pipeline drugs in…
Chronic Obstructive Pulmonary Disease Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Chronic Obstructive Pulmonary Disease Pipeline Insight 2024" report provides comprehensive insights about 65+ companies and 70+ pipeline drugs in Chronic Obstructive Pulmonary Disease pipeline…
Chronic Lymphocytic Leukemia Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Chronic Lymphocytic Leukemia Pipeline Insight 2024" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia pipeline landscape. It…
